Bone Pain Due to PEG G-CSF. Non-follicular lymphoma
Conditions
Interventions
Intervention 1: Intervention group:? The target intervention group (main): noscough syrup 15 cc daily orally, manufactured by Faran Chemi factory, and the duration of use is considered from the onset
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with solid tumor or lymphoma Candidate for receiving Pegfilgrastim -after chemotherapy based on well known chemotherapy protocol
Exclusion criteria
Exclusion criteria: Bone metastasis in patients with progression free survival(PFS )greater than 2 Test-proven osteomalacia chronic kidney disease or end stage renal disease patients Patients with active rheumatic disease diabetes Uncontrolled thyroid disease Patients receiving chemotherapy drugs in which bone pain is one of the complications with a high incidence of 10% (TAXAN family, bisphosphonate.) Patients with pathological fracture or fracture due to any other reason Opioid addicts Contraindications for taking naproxen and methadone and other similar drugs Vitamin D level less than 20 Paget's disease Hyperparathyroid disease Patients who have bone pains in the questionnaire with a score above 6 since the beginning of the project liver disease Patients with a history of cardiac arrhythmia Patients who do not have the appropriate admission to fill out the pain questionnaire
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Score in Visual Analogue Scale(VAS) questionnaire. Timepoint: One day after the end of the first, second, third and fourth course of chemotherapy. Method of measurement: Visual Analogue Scale questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Talebian Taheri
Shahid Beheshti University of Medical Sciences
Outcome results
None listed